Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands	9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Cash flow from operating activities:
Net income	$ 69,048	$ 102,089
Adjustments to reconcile net income to cash flow from operating activities:
Depreciation and amortization	58,638	59,242
Share-based compensation	10,506	9,424
Excess tax benefits from share-based compensation	(1,390)	(295)
Devaluation of Venezuelan balance sheet		5,148
Impairment of intangible assets	2,962	7,096
Gain on sale of assets, net	(540)	(511)
Equity in earnings of an investee	(1,448)	(2,106)
Cash flow from changes in certain assets and liabilities:
Trade receivables	(36,418)	(99,647)
Inventories	(84,179)	(37,213)
Prepaid expenses	5,170	7,845
Refundable income taxes	(7,365)	74,468
Other current assets	(40,309)	(26,363)
Accounts payable	3,271	28,977
Deferred revenue	2,751	(28,777)
Certain other assets and liabilities	(35,361)	(48,304)
Net cash (used in) provided by operating activities	(54,664)	51,073
Cash flow from investing activities:
Proceeds from sale of discontinued operations	2,520	1,815
Proceeds from maturities of investments	206,283	254,570
Proceeds from sale of investments	43,182	35,624
Payments for purchases of investments	(209,663)	(303,745)
Proceeds from sale of assets	746	749
Capital expenditures	(38,456)	(37,991)
Purchase of finance receivables, net of cash collections	17,826	(18,939)
Increase in certain other assets	(18,092)	(17,614)
Net cash provided by (used in) investing activities	4,346	(85,531)
Cash flow from financing activities:
Dividends paid	(55,146)	(53,989)
Debt issuance costs	(1,864)
Debt borrowings	477,331	371,390
Debt repayments	(338,583)	(345,003)
Distribution of affiliates earnings to noncontrolling interest holders	(5,868)	(1,226)
Excess tax benefits from share-based compensation	1,390	295
Issuance of common shares	4,017	1,750
Repurchase of common shares	(104,852)	(24,786)
Net cash used in financing activities	(23,575)	(51,569)
Effect of exchange rate changes on cash and cash equivalents	2,049	(2,576)
Decrease in cash and cash equivalents	(71,844)	(88,603)
Cash and cash equivalents at the beginning of the period	328,658	328,426
Cash and cash equivalents at the end of the period	256,814	239,823
Significant noncash investing and financing activities:
Finance receivables acquired		33,843
Liabilities assumed related to acquisition of finance receivables		$ 20,861